FDA
approval
· 2009-07-09
FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
Summary
FDA approved TEVA Pharmaceuticals USA Inc.'s supplemental application for glyburide. The drug is used to treat type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLYBURIDE (GLYBURIDE)